<code id='039F63E8F4'></code><style id='039F63E8F4'></style>
    • <acronym id='039F63E8F4'></acronym>
      <center id='039F63E8F4'><center id='039F63E8F4'><tfoot id='039F63E8F4'></tfoot></center><abbr id='039F63E8F4'><dir id='039F63E8F4'><tfoot id='039F63E8F4'></tfoot><noframes id='039F63E8F4'>

    • <optgroup id='039F63E8F4'><strike id='039F63E8F4'><sup id='039F63E8F4'></sup></strike><code id='039F63E8F4'></code></optgroup>
        1. <b id='039F63E8F4'><label id='039F63E8F4'><select id='039F63E8F4'><dt id='039F63E8F4'><span id='039F63E8F4'></span></dt></select></label></b><u id='039F63E8F4'></u>
          <i id='039F63E8F4'><strike id='039F63E8F4'><tt id='039F63E8F4'><pre id='039F63E8F4'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:1292
          Glaxo Smith Kline
          Akira Suemori/AP

          A few years ago, Vijay Pande, then a professor at Stanford who was using computer science to understand biology, was deciding whether to leave full-time academic work to become a venture capitalist. He turned to Andrew Ng, another Stanford professor who had joined Google Brain and later the Chinese search firm Baidu.

          “The things that we dreamed about five or 10 years ago were happening now,” Pande recalled Ng telling him. “The question was, do you want to be a part of it? Or do you want to write another paper?”

          advertisement

          Pande decided to become a venture capitalist. The result, he told an audience at a STAT event in San Francisco last week, is that, whereas he managed about $1 million to $2 million in research as a top academic, he now works at the fabled Silicon Valley firm Andreessen Horowitz, which invests $100 million a year.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more
          A single drug, study failures leave Anavex with nothing but cash
          A single drug, study failures leave Anavex with nothing but cash

          MollyFerguson/STATIttookAnavexLifeSciencessevenmonthstofinallyacknowledgethefailureofalate-stageclin

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          Hyaluronic acid injections don’t help knee osteoarthritis, study finds

          AdobeAcommonlyusedtreatmentforpeoplewithkneeosteoarthritisisbarelymoreeffectivethantheplaceboeffecti